Literature DB >> 2438299

Nonvalue of sputum culture in the management of lower respiratory tract infections.

J R Lentino, D A Lucks.   

Abstract

Establishment of the microbiological etiology of bacterial pneumonia by sputum culture is confounded by both lack of recovery of fastidious pathogens and contamination of specimens with oropharyngeal flora. We reviewed the clinical records from 249 patients over a 3-month period for evidence of pneumonia. Gram staining and cultures were performed on 381 specimens isolated from this population of patients. Recovery of respiratory tract pathogens was accomplished with 354 specimens from 226 patients; 27 specimens yielded normal flora in culture but were smear positive. An additional 256 specimens submitted to our microbiology laboratory did not meet smear criteria for purulence nor did they yield respiratory tract pathogens in culture. A total of 637 specimens submitted to the microbiology laboratory were evaluated for sputum purulence by the criteria of Bartlett. Of the total 354 specimens which were positive in culture for a pathogen, 182 (52%) were submitted from 150 patients with no objective evidence of pneumonia. The majority of specimens obtained from patients without pneumonia were nonpurulent. However, 71 of 182 culture-positive specimens obtained from 50 patients without pneumonia were purulent. Approximately half of these patients (31 of 50) had other pulmonary or upper respiratory tract pathology which could account for the sputum purulence. Among the 172 culture-positive specimens from 76 patients with pneumonia, only 100 (58%) were acceptable by smear criteria. An additional 23 patients provided expectorated purulent sputum from which no respiratory tract pathogen could be isolated. Of these 23, 7 had pneumonia. We conclude that sputum culture and Gram staining are neither specific nor sensitive as diagnostic tools. Objective criteria for purulence of Gram-stained specimens must be applied before their inoculation into culture media. Specimens should be sought only from patients with objective evidence of pneumonia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438299      PMCID: PMC266084          DOI: 10.1128/jcm.25.5.758-762.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Bacteriologic diagnosis of acute pneumonia. Comparison of sputum, transtracheal aspirates, and lung aspirates.

Authors:  M Davidson; B Tempest; D L Palmer
Journal:  JAMA       Date:  1976-01-12       Impact factor: 56.272

2.  Microscopic and baceriologic analysis of expectorated sputum.

Authors:  P R Murray; J A Washington
Journal:  Mayo Clin Proc       Date:  1975-06       Impact factor: 7.616

3.  Sinusitis of the maxillary antrum.

Authors:  F O Evans; J B Sydnor; W E Moore; G R Moore; J L Manwaring; A H Brill; R T Jackson; S Hanna; J S Skaar; L V Holdeman; S Fitz-Hugh; M A Sande; J M Gwaltney
Journal:  N Engl J Med       Date:  1975-10-09       Impact factor: 91.245

Review 4.  The protean manifestations of Mycoplasma pneumoniae infection in adults.

Authors:  H W Murray; H Masur; L B Senterfit; R B Roberts
Journal:  Am J Med       Date:  1975-02       Impact factor: 4.965

5.  The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia.

Authors:  E Barrett-Connor
Journal:  Am Rev Respir Dis       Date:  1971-06

6.  A study of the combined role of viruses, mycoplasmas and bacteria in adult pneumonia.

Authors:  M Fiala
Journal:  Am J Med Sci       Date:  1969-01       Impact factor: 2.378

7.  The role of viruses, mycoplasmas and bacteria in acute pneumonia in civilian adults.

Authors:  M A Mufson; V Chang; V Gill; S C Wood; M J Romansky; R M Chanock
Journal:  Am J Epidemiol       Date:  1967-11       Impact factor: 4.897

8.  Mycoplasma infections in patients with chronic obstructive pulmonary disease.

Authors:  S C Westerberg; C B Smith; A D Renzetti
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

9.  Transtracheal aspiration in the evaluation of patients with pneumonia.

Authors:  H H Hahn; H N Beaty
Journal:  Ann Intern Med       Date:  1970-02       Impact factor: 25.391

10.  Diagnostic usefulness and safety of transtracheal aspiration.

Authors:  R W Kalinske; R H Parker; D Brandt; P D Hoeprich
Journal:  N Engl J Med       Date:  1967-03-16       Impact factor: 91.245

View more
  38 in total

1.  Sampling variability in the microbiological evaluation of expectorated sputa and endotracheal aspirates.

Authors:  S Nagendra; P Bourbeau; S Brecher; M Dunne; M LaRocco; G Doern
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

2.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

Review 3.  Molecular biology and respiratory disease. 6. Modern molecular biology and respiratory bacterial infections: a revolution on the horizon.

Authors:  T F Murphy
Journal:  Thorax       Date:  1990-07       Impact factor: 9.139

4.  Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients.

Authors:  Samuel Yang; Shin Lin; Ambreen Khalil; Charlotte Gaydos; Eric Nuemberger; George Juan; Justin Hardick; John G Bartlett; Paul G Auwaerter; Richard E Rothman
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

Review 6.  Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections.

Authors:  K Loens; L Van Heirstraeten; S Malhotra-Kumar; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

7.  Sputum gram's stain in community-acquired pneumococcal pneumonia. A meta-analysis.

Authors:  W W Reed; G S Byrd; R H Gates; R S Howard; M J Weaver
Journal:  West J Med       Date:  1996-10

8.  Roxithromycin versus cefaclor in lower respiratory tract infection: a general practice pharmacoeconomic study.

Authors:  W G Scott; M W Tilyard; S M Dovey; B Cooper; H M Scott
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

9.  Diagnosis of nosocomial pneumonia in mechanically ventilated patients by the blind protected telescoping catheter.

Authors:  R Jordá; F Parras; J Ibañez; J Reina; J Bergadá; J M Raurich
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 10.  Improving outcomes of elderly patients with community-acquired pneumonia.

Authors:  Félix Gutiérrez; Mar Masiá
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.